Nevan Krogan, PhD

Nevan Krogan, PhD, is a molecular biologist and professor at the University of California, San Francisco (UCSF) where he is the director of the Quantitative Biosciences Institute (QBI) under the School of Pharmacy. His research focuses on developing and using unbiased, quantitative systems approaches to study a wide variety of diseases with the ultimate goal of developing new therapeutics.

Dr. Krogan serves as the director of the HIV Accessory & Regulatory Complexes (HARC) Center and co-directs the Cancer Cell Mapping Initiative (CCMI), the Host Pathogen Map Initiative (HPMI), the Psychiatric Cell Map Initiative (PCMI), and the QCRG Antiviral Drug Discovery (AViDD) grant. He is also a senior investigator at the Gladstone Institutes. He led work to create the SARS-CoV-2 interactome and assembled the QBI Coronavirus Research Group (QCRG).

He is a Searle scholar, a Keck Distinguished scholar, a recipient of the Roddenberry Prize for Biomedical Research, and was recently elected to the European Molecular Biology Organization (EMBO). Dr. Krogan was awarded the French Legion of Honor in 2021, the Louis Pasteur Medal in 2022, and the Research!America Discovery | Innovation | Health Prize in 2023, and an Einstein Foundation Visiting Fellowship in 2025.